Join our email list to stay up to date on the latest Amyloidosis news.
In this ARC TALKS webinar, Dr. Heather Landau will discuss current treatment options for relapsed and refractory AL amyloidosis patients.
Dr. Landau will also discuss the current testing methodology used to monitor a patient’s disease status, and the role maintenance therapy may play in the management of relapsed AL amyloidosis.
In addition to describing considerations that may factor into recommended treatment plans for patients, Dr. Landau will share details on novel therapies being evaluated in clinical trials.